Title	Publication Date	Language	Citations
Antiplatelet agents	2004/01/01		8
Heterozygous prothrombin 20210G/A mutation, associated with hyperhomocysteinemia, and homozygous methylenetetrahydrofolate reductase 677C/T mutation, in a patient with portal and mesenteric venous thrombosis	2004/01/01		8
In vitro effects of interferon-γ and tumor necrosis factor-α on CD34+ bone marrow progenitor cells from aplastic anemia patients and normal donors	2004/01/01		8
Efficient ex vivo expansion of NOD/SCID-repopulating cells with lympho-myeloid potential in hematopoietic grafts of children with solid tumors	2001/01/01		8
Hypothesis for generation of the unstable Hb Bucuresti (β 42 Phe→Leu) mutation	2001/01/01		8
High-dose idarubicin and busulphan as conditioning for autologous stem cell transplantation in acute myeloid leukemia: a feasibility study	2001/01/01		8
Phase II study of cyclophosphamide, interferon-α and betamethasone (CIB) as induction therapy for patients 60–75 years of age with multiple myeloma stages II and III	2003/01/01		8
Successful paternity with microassisted fertilization after total body irradiation-based conditioning for autologous bone marrow transplantation	2003/01/01		8
Oral fludarabine therapy in chronic lymphocytic leukemia - increased convenience	2004/01/01		8
Impaired T-cell activation and cytokine productivity after transplantation of positively selected CD34+ allogeneic hematopoietic stem cells	2004/01/01		8
Central role of leukemia-derived factors in the development of leukemia-associated immune dysfunction	2001/01/01		7
A case of pancreatitis associated with all-trans-retinoic acid therapy in acute promyelocytic leukemia	2001/01/01		7
Red cell membrane and erythropoiesis genetic defects	2003/01/01		7
Malignant diseases of hematopoietic and lymphoid tissues in Chernobyl clean-up workers	2005/01/01		7
Chronic myelogenous leukemia with acquired c-kit activating mutation and transient bone marrow mastocytosis	2004/01/01		7
Second autologous transplantation after failure of a first autologous transplant in 18 patients with non-Hodgkin's lymphoma	2004/01/01		7
Erythropoietin and erythropoiesis: polycythemias due to disruption of oxygen homeostasis	2004/01/01		7
Overview of transplant activity in Europe	2004/01/01		7
Haemovigilance procedure in transfusion medicine	2004/01/01		7
Rescue therapy combining intermediate-dose cytarabine with amsacrine and etoposide in relapsed adult acute lymphoblastic leukemia	2004/01/01		7
Unexpectedly high but still asymptomatic iron overload in a patient with pyruvate kinase deficiency	2004/01/01		6
Perspective study on pamidronate in stage I multiple myeloma	2003/01/01		6
Multicolor fluorescence in situ hybridization studies in multiple myeloma and monoclonal gammopathy of undetermined significance	2003/01/01		6
Stimulation of T-cell cytokine production and NK-cell function by IL-2, IFN-α and histamine treatment during remission of non-Hodgkin's lymphoma	2003/01/01		6
Treatment options in chronic lymphocytic leukemia	2004/01/01		6
Treatment of hematological malignancies with allogeneic nonmyeloablative stem cell transplantation: conditioning regimens with fludarabine	2004/01/01		6
Chronic lymphocytic leukaemia: new biological markers for assessing prognosis	2004/01/01		6
A single administration of gemtuzumab ozogamicin for molecular relapse of acute promyelocytic leukemia	2004/01/01		6
Somatostatin modulates G-CSF-induced but not interleukin-3-induced proliferative responses in myeloid 32D cells via activation of somatostatin receptor subtype 2	2001/01/01		6
Decreased function of Fas in patients displaying delayed progression of HIV-induced immune deficiency	2001/01/01		6